Intellia Therapeutics’ $300 Million Common Stock Offering

Laura Testa North America Legal Chronicle
Tagged:

Goodwin Procter represented Intellia Therapeutics, while Latham & Watkins LLP represented the underwriter in the offering.Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here